Literature DB >> 10192289

Boranophosphates support the RNase H cleavage of polyribonucleotides.

V K Rait1, B R Shaw.   

Abstract

Modification of the phosphodiester linkages in DNA by replacing one of the nonbridging oxygens with borane, BH3, produces an isoelectronic mimic of DNA called boranophosphates. Nonstereoregular oligodeoxyribonucleoside all-boranophosphates are shown here for the first time to elicit the RNase H hydrolysis of polyribonucleotides. We compared the ability of three types of dodecamers (dodecathymidine phosphate, phosphorothioate, and boranophosphate) to mediate the cleavage of poly(A) by Escherichia coli RNase H1. The rates of poly(A) hydrolysis induced by boranophosphates were 76-fold (at 20 degrees C) and 18-fold (at 30 degrees C) greater than the rates induced by dodecathymidine phosphate. In conjunction with the measured melting temperatures for each heteroduplex, carried out under the same conditions as the RNAse H cleavage experiments, the data establish an inverse relationship between the heteroduplex thermostability and the rate of poly(A) hydrolysis. Chromatographic analysis revealed another correlation: the higher the heteroduplex Tm, the higher the pApA:pApApA ratio in the corresponding hydrolysates. The specific content of these final products provides insight into the relative contribution of RNase H1 exonucleolytic/endonucleolytic mechanisms, with a low ratio for the lower melting heteroduplexes reflecting more endonucleolytic-type hydrolysis. In total, our data support the concept that antisense molecules with a weakened hybridization potential enhance the rate of hydrolysis of RNA in RNA-DNA hybrids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192289     DOI: 10.1089/oli.1.1999.9.53

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  8 in total

1.  RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).

Authors:  B Verbeure; E Lescrinier; J Wang; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Boron-containing aptamers to ATP.

Authors:  Susan M Lato; Nicole D S Ozerova; Kaizhang He; Zinaida Sergueeva; Barbara Ramsay Shaw; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

3.  Structural basis of the RNase H1 activity on stereo regular borano phosphonate DNA/RNA hybrids.

Authors:  Christopher N Johnson; Alexander M Spring; Dimitri Sergueev; Barbara R Shaw; Markus W Germann
Journal:  Biochemistry       Date:  2011-04-19       Impact factor: 3.162

Review 4.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

5.  RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.

Authors:  Margit Mutso; Andrei Nikonov; Arno Pihlak; Eva Žusinaite; Liane Viru; Anastasia Selyutina; Tõnu Reintamm; Merike Kelve; Mart Saarma; Mati Karelson; Andres Merits
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 6.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

7.  A New 1,5-Disubstituted Triazole DNA Backbone Mimic with Enhanced Polymerase Compatibility.

Authors:  Sven Epple; Aman Modi; Ysobel R Baker; Ewa Wȩgrzyn; Diallo Traoré; Przemyslaw Wanat; Agnes E S Tyburn; Arun Shivalingam; Lapatrada Taemaitree; Afaf H El-Sagheer; Tom Brown
Journal:  J Am Chem Soc       Date:  2021-09-21       Impact factor: 15.419

8.  5'-O-Methylphosphonate nucleic acids--new modified DNAs that increase the Escherichia coli RNase H cleavage rate of hybrid duplexes.

Authors:  Hana Šipova; Tomaš Špringer; Dominik Rejman; Ondřej Šimak; Magdalena Petrová; Pavel Novák; Šarka Rosenbergová; Ondřej Páv; Radek Liboska; Ivan Barvík; Josef Štěpanek; Ivan Rosenberg; Jiři Homola
Journal:  Nucleic Acids Res       Date:  2014-02-12       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.